What is Dermisonics, Inc. (DMSI) stock price today?

Dermisonics, Inc. (DMSI) is currently trading at $0.00.

What is DMSI P/E ratio?

Dermisonics, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is DMSI return on equity (ROE)?

Dermisonics, Inc.'s return on equity (ROE) is -31.25%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Dermisonics, Inc.'s market cap?

Dermisonics, Inc. has a market capitalization of $1917.

OTC · Medical - Specialties

Dermisonics, Inc. (DMSI) Stock

$0.00 OTC: DMSI Healthcare

Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications.

Valuation

Metric	Value
Price	$0.00
Market Cap	$1917
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.12
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-31.25%
ROA	-25.00%
ROCE	-27.73%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.19
Current Ratio	0.25

Annual Financials (USD)

Metric	2003	2004	2005	2006
Revenue	$0	$0	$0	$0
Operating Profit	$0	$0	$-6.0M	$-4.0M
Net Profit	$0	$-4.0M	$-7.0M	$-5.0M
EPS	$0.00	$-0.27	$-0.17	$-0.12
Op Margin	—	—	—	—

Balance Sheet (USD)

Metric	2003	2004	2005	2006
Total Assets	$0	$19.0M	$20.0M	$20.0M
Total Liabilities	$0	$3.0M	$4.0M	$4.0M
Cash	$0	$0	$0	$0
Borrowings	$0	$2.0M	$4.0M	$3.0M

Cash Flow (USD)

Metric	2003	2004	2005	2006
Operating Cash Flow	$0	$0	$-1.0M	$-1.0M
Investing Cash Flow	$0	$-1.0M	$0	$0
Financing Cash Flow	$0	$0	$0	$-1.0M
Net Cash Flow	$0	$0	$0	$0
Free Cash Flow	$0	$-1.0M	$-1.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.67
FCF Yield	-68225.40%
Quick Ratio	0.14
Interest Coverage	-7.53
Return 1Y	0.00%
Return 3Y	-70.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
569.SIVicplas International Ltd	$0.07	+0.00%	-7.00	$33.73M	0.00%
CLVSFCellaVision AB (publ)	$14.00	+0.00%	27.39	$333.92M	2.14%
DNAGDNAPrint Genomics, Inc.	$0.00	—	—	$12892	0.00%
GGNDFGN Store Nord A/S	$13.39	+0.00%	-35.71	$1.95B	0.00%
HESGHealth Sciences Group, Inc.	$0.00	—	0.00	$1.87M	0.00%

About Dermisonics, Inc.

Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.

Dermisonics, Inc. (DMSI) stock trades at $0.00 with a market capitalization of $1917. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Dermisonics, Inc. generates a return on equity (ROE) of -31.25%, return on capital employed of -27.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.dermisonics.com